Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$0.5 - $1.05 $226,715 - $476,101
453,430 New
453,430 $272,000
Q2 2022

Aug 15, 2022

SELL
$0.94 - $1.94 $55,648 - $114,848
-59,200 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$1.54 - $3.71 $24,193 - $58,284
15,710 Added 36.12%
59,200 $117,000
Q4 2021

Feb 14, 2022

BUY
$2.58 - $3.91 $112,204 - $170,045
43,490 New
43,490 $116,000
Q1 2020

May 15, 2020

SELL
$0.56 - $1.62 $37,072 - $107,244
-66,200 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$0.97 - $1.94 $5,044 - $10,088
-5,200 Reduced 7.28%
66,200 $65,000
Q2 2019

Aug 14, 2019

BUY
$1.81 - $2.45 $5,792 - $7,840
3,200 Added 4.69%
71,400 $146,000
Q1 2019

May 15, 2019

BUY
$2.3 - $3.27 $71,300 - $101,370
31,000 Added 83.33%
68,200 $167,000
Q4 2018

Feb 14, 2019

BUY
$2.49 - $4.54 $92,628 - $168,888
37,200 New
37,200 $96,000

Others Institutions Holding SENS

About Senseonics Holdings, Inc.


  • Ticker SENS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 465,447,008
  • Market Cap $475M
  • Description
  • Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with ...
More about SENS
Track This Portfolio

Track Man Group PLC Portfolio

Follow Man Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.